"No compromise on public health": AIOCD strongly opposes proposal to grant drug licenses to PACS - ANI News

Consumers want products that deliver more nutrition and functionality while still meeting expectations for taste, texture, convenience, and value. What do today’s consumers expect from healthier foods? At IFT FIRST, Food Technology editors spoke with experts across the Expo Hall and online about the forces shaping health and wellness innovation. One trend came through clearly: Consumers want foods that do more for them, from delivering protein, fiber, gut health benefits, vitamins, and minerals to meeting the nutritional needs associated with smaller portions. But they still expect satisfying taste and texture at the right price. See how food and ingredient companies are responding with ingredient innovation and product solutions designed to deliver meaningful nutrition without compromise.

Affiliates of the Fairshake political action committee (PAC), largely funded by Coinbase and Ripple Labs, have increased their initially announced expenditures by more than 50% in what could be a key race for control of Congress in 2026. According to Thursday filings with the Federal Election Commission (FEC), the Fairshake affiliate Defend American Jobs — a group that supports Republican candidates in primaries and elections — spent $46.6 million on media opposing former lawmaker Sherrod Brown and supporting Republican incumbent Jon Husted in Ohio’s Senate race for the 2026 midterms. The spending marked a sharp increase over what Fairshake said in September it initially planned to spend opposing Brown’s return to the Senate: $30 million. “I’ve spent my career taking on Wall Street, taking on big pharma, taking on big oil and been successful in many cases,” said Brown in an interview aired Friday on Pod Save America, addressing the attack ads funded by the crypto industry, adding:“Jon Husted is their boy [...]

A common liver disease affecting nearly 30% of adults worldwide is far more complex than previously understood. Researchers at Mayo Clinic have identified five biologically distinct forms of the condition, each associated with different risks of serious health complications, including heart disease, liver failure, cancer, and the need for a liver transplant. The findings, published in Nature Communications, come from a collaboration between Mayo Clinic and Virginia Tech. Scientists discovered that metabolic dysfunction-associated steatotic liver disease, or MASLD, can develop through several different biological pathways. Some are closely connected to obesity and diabetes, while others appear to be driven by inherited genetic differences.

IntroductionHypertension is a major global health concern and a leading cause of morbidity and mortality [1]. It is estimated that more than 19 million annual deaths are attributed to cardiovascular disease (CVD) worldwide [2]. In Japan, high blood pressure (BP) has been consistently identified as a strong risk factor for the national burden of CVD, in terms of notable incidence, mortality, direct/indirect healthcare costs, and quality-adjusted life years (QALYs) associated with this condition [3, 4]. Although age-specific mean BP declined in Japan over recent decades [5], hypertension remains a critical public health issue, particularly because of the rapid aging population. The proportion of individuals aged ≥65 years is projected to reach approximately 35% by 2040 in Japan [6], highlighting a potentially higher future burden of hypertension in this country. While the prevalence of hypertension increases with age, population aging may offset the benefits of declining BP levels in each age group. As a result, the future burden of hypertension in Japan remains uncertain.

It also established a $2.5m professorship to support its cardiothoracic surgery leadership. The National Heart Centre Singapore (NHCS) has launched a centre to develop cardiovascular disease models using heart cells derived from Asian patients. The Centre for Integrative Human Cell Research and Translation (CIPHER), launched on 16 October, uses blood samples from Asian patients to grow heart muscle cells for disease research and drug testing. It is the first centre in Singapore dedicated to cardiovascular research using this approach. NHCS also announced the establishment of the Tong Ming Chuan Professorship in Cardiothoracic Surgery, the first professorship in the field under the SingHealth Duke-NUS Academic Medical Centre (AMC). CIPHER aims to address gaps in cardiovascular research, as some heart conditions develop earlier and present differently in Asian populations than in Western populations. Many treatments have historically been developed using models that do not fully reflect Asian biology. The centre uses blood samples to generate induced pluripotent stem cells, which are developed into heart muscle cells carrying features of each patient’s disease.